Home/Filings/4/0001209191-20-039138
4//SEC Filing

Lee Tom Y 4

Accession 0001209191-20-039138

CIK 0001006028other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 5:37 PM ET

Size

9.1 KB

Accession

0001209191-20-039138

Insider Transaction Report

Form 4
Period: 2020-06-24
Lee Tom Y
Director
Transactions
  • Other

    Common Stock

    2020-06-2410,732,22213,401,951 total(indirect: By Plum Investments, L.P.)
Holdings
  • Common Stock

    (indirect: By Trust)
    1,000,000
  • Common Stock

    (indirect: By Trust)
    1,000,000
  • Common Stock

    (indirect: By Spouse)
    717,665
  • Common Stock

    4,617,647
  • Common Stock

    (indirect: By Trust)
    1,000,000
Footnotes (3)
  • [F1]The shares were distributed on a pro rata basis by Plum Investments, L.P., for no consideration.
  • [F2]Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P.
  • [F3]Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019, Karissa Shay Lee Trust Dated July 1, 2019 and Tessa Melody Shin Trust Dated February 12, 2020 and has voting and dispositive power with respect to these shares

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1
  • filerCIK 0001623609

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 5:37 PM ET
Size
9.1 KB